Goldman Sachs Group Inc Adamas Pharmaceuticals, Inc. Transaction History
Goldman Sachs Group Inc
- $613 Billion
- Q4 2024
About Adamas Pharmaceuticals, Inc.
- Ticker ADMS
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,408,100
- Market Cap $376M